Informations générales (source: ClinicalTrials.gov)

NCT04954274 En recrutement IDF
Improvement of Live Babies Rates After ICSI, Using cpFT: Multicenter Prospective Randomized Clinical Trial
Interventional
  • Infertilité
Phase 3
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
juillet 2021
juillet 2026
17 septembre 2025
Demonstrate the improvement of the live births rate after ICSI by supplementing the pre-ICSI incubation medium of oocytes and that of preimplantation embryos with cpFT at the 1st embryo transfer for women under 37 years old.
 Voir le détail

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
CH DES QUATRE VILLES SITE ST CLOUD WOLF Jean-philippe En recrutement IDF 18/09/2025 17:39:01  Contacter
CLINIQUE DE LA MUETTE WOLF Jean-philippe En recrutement IDF 18/09/2025 17:39:01  Contacter
HOPITAL DE LA CROIX SAINT SIMON WOLF Jean-philippe En recrutement IDF 18/09/2025 17:39:01  Contacter
HOPITAL PIERRE ROUQUES LES BLUETS WOLF Jean-philippe En recrutement IDF 18/09/2025 17:39:01  Contacter
AP-HP Assistance publique - Hôpitaux de Paris En recrutement IDF 18/09/2025 17:39:01  Contacter
AP-HP - Hôpital Bichat
AP-HP - Hôpital Cochin
AP-HP - Hôpital Jean Verdier
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
18/09/2025 17:39:01 Contact (sur clinicalTrials)

Critères

Femme
Inclusion Criteria:

- Couples eligible for a first attempt at Assisted Reproduction (AMP).

- Couples asking for Assisted Reproductive Technology, and requiring an ICS procedure.

- Women aged 18 to 36 inclusive.

- Men aged 18 to 58 inclusive

- Use of CSCM-C culture medium from Biocare / Irvine, exclusively.

- People affiliated to a Social Security scheme



- Lack of consent

- Early menopause.

- Couples under IVF or Intra Uterine Insemination treatment.

- People unable to follow protocol visits in France.

- Couple with a contraindication to treatment with ART.

- Women with a contraindication to treatment with ART or an associated pathology such
as: hypertension, risk of eclampsia, family genetic problems, diabetes, uterine
partitions, synechiae adhesions, adenomyosis or any other contraindication judged as
such by the investigator.

- ART with donation of gametes or embryos.

- Participant under guardianship or guardianship